Ethical concerns regarding olanzapine versus placebo in patients prodromally symptomatic for psychosis.
Block
Jerald J
JJ
D000293:Adolescent; D000367:Age Factors; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D004992:Ethics, Medical; D032984:Ethics, Research; D005260:Female; D006625:Hippocratic Oath; D006801:Humans; D008297:Male; D009765:Obesity / Q000139:chemically induced; D000077152:Olanzapine; D010919:Placebos; D016032:Randomized Controlled Trials as Topic / Q000941:ethics; D012559:Schizophrenia / Q000175:diagnosis / Q000517:prevention & control*; D012565:Schizophrenic Psychology; D015430:Weight Gain / Q000187:drug effects
D014150:Antipsychotic Agents; D010919:Placebos; D001569:Benzodiazepines; D000077152:Olanzapine